Literature DB >> 2909030

The relationship of one abnormal glucose tolerance test value and pregnancy complications.

M K Lindsay1, W Graves, L Klein.   

Abstract

While an abnormal oral glucose tolerance test (GTT) is known to be associated with an increased risk of pregnancy complications, the impact of one abnormal value is not clear. In 1986 we screened 4618 pregnant women for gestational diabetes at 24-28 weeks' gestation. Eighty-seven percent had normal results; of the 13% with abnormal screening tests, 139 had one abnormal value on the subsequent 3-hour oral GTT. These women were then compared with 725 randomly selected patients with a normal screening test. The frequency of chronic hypertension, cesarean section, 5-minute Apgar score below 7, preterm delivery, shoulder dystocia, congenital malformations, and perinatal mortality did not differ significantly between the groups. The incidence of macrosomia (birth weight above 4000 g) was significantly greater in the study group (18.0%) than in the control group (6.6%) (odds ratio 2.18; 95% confidence interval 1.77-5.37), a relationship that persisted after controlling for confounding risk factors by logistic regression modeling (odds ratio 2.55; 95% confidence interval 1.44-4.52). The incidence of preeclampsia/eclampsia was significantly greater in the study group (7.9%) than in the control group (3.3%) (odds ratio 2.51; 95% confidence interval 1.14-5.52), which also persisted after controlling for confounding risk factors using logistic regression modeling (odds ratio 2.81; 95% confidence interval 1.26-6.28). Our results suggest that patients with one abnormal value on an oral GTT during pregnancy are at risk for delivering macrosomic infants and developing preeclampsia/eclampsia.

Entities:  

Mesh:

Year:  1989        PMID: 2909030

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  11 in total

1.  Gestational diabetes mellitus: can we reach consensus?

Authors:  Carol J Homko
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

2.  Comparison of the criteria forgestational diabetes mellitus by NDDG and Carpenter and Coustan, and the outcomes of pregnancy.

Authors:  A Gokcel; T Bagis; E B Killicadag; E Tarim; N Guvener
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

3.  Prevalence of gestational diabetes mellitus among James Bay Cree women in northern Quebec.

Authors:  S Rodrigues; E Robinson; K Gray-Donald
Journal:  CMAJ       Date:  1999-05-04       Impact factor: 8.262

Review 4.  Detecting and managing gestational diabetes.

Authors:  M M Blair; A M Noc
Journal:  Can Fam Physician       Date:  1993-04       Impact factor: 3.275

5.  Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Juan Pedro Kusanovic; Edi Vaisbuch; Offer Erez; Nandor Gabor Than; Tinnakorn Chaiworapongsa; Chia-Ling Nhan-Chang; Percy Pacora; Francesca Gotsch; Lami Yeo; Sun Kwon Kim; Samuel S Edwin; Sonia S Hassan; Pooja Mittal
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

Review 6.  The utility of a single test to identify women at risk for gestational diabetes.

Authors:  D A Sacks
Journal:  Curr Diab Rep       Date:  2001-08       Impact factor: 4.810

7.  Gestational diabetes mellitus: challenges in diagnosis and management.

Authors:  Bonaventura C T Mpondo; Alex Ernest; Hannah E Dee
Journal:  J Diabetes Metab Disord       Date:  2015-05-12

8.  The Relationship between Maternal Gestational Impaired Glucose Tolerance and Risk of Large-for-Gestational-Age Infant: A Meta-Analysis of 14 Studies.

Authors:  Hai Qing Wang; Han Lin Lai; Yi Li; Qi Fei Liu; Shuang Hu; Li Li
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-04-18

9.  Diagnosing gestational diabetes mellitus: rationed or rationally related to risk?

Authors:  Harold David McIntyre
Journal:  Diabetes Care       Date:  2013-10       Impact factor: 19.112

10.  Diversified microbiota of meconium is affected by maternal diabetes status.

Authors:  Jianzhong Hu; Yoko Nomura; Ali Bashir; Heriberto Fernandez-Hernandez; Steven Itzkowitz; Zhiheng Pei; Joanne Stone; Holly Loudon; Inga Peter
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.